Cyfuse Biomedical is a regenerative medicine venture that develops and commercializes three-dimensional cell-only tissue and organ products ('3D cell products') using its proprietary platform technology combining spheroids and bio-3D printers. The company operates across three segments: (1) regenerative medicine, developing pipeline products such as cell-based nerve conduits, osteochondral grafts, and vascular grafts; (2) drug discovery support, providing 3D cell-based in vitro evaluation tools (including human liver function models) to pharmaceutical and CRO clients; and (3) device, developing and selling bio-3D printer systems. Its key competitive strength lies in fabricating transplantable tissues without artificial scaffolding materials, enabling high biocompatibility and reduced rejection risk.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Cyfuse Biomedical is a regenerative medicine venture that develops and commercializes three-dimensional cell-only tissue and organ products ('3D cell products') using its proprietary platform technology combining spheroids and bio-3D printers. The company operates across three segments: (1) regenerative medicine, developing pipeline products such as cell-based nerve conduits, osteochondral grafts, and vascular grafts; (2) drug discovery support, providing 3D cell-based in vitro evaluation tools (including human liver function models) to pharmaceutical and CRO clients; and (3) device, developing and selling bio-3D printer systems. Its key competitive strength lies in fabricating transplantable tissues without artificial scaffolding materials, enabling high biocompatibility and reduced rejection risk.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →